Gene · 5892
Papers2,681
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,681
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Response to Carboplatin and Paclitaxel in the treatment of hereditary breast ovarian cancer syndrome (HBOC): a case report. | J Pak Med Assoc | 2024 | 39658994 | PubTator, text mining | PubMed |
A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma. | Front Oncol | 2024 | 39640282 | PubTator, text mining | PubMed |
| Germline Variants in DNA Interstrand-Cross Link Repair Genes May Contribute to Increased Susceptibility for Serrated Polyposis Syndrome. | Int J Mol Sci | 2024 | 39519399 | PubTator, text mining | PubMed |
| Germline genetic variants in a case of familial cancer: RAD51D and four other co-segregated variants. | J Genet | 2024 | 39445568 | PubTator, text mining | PubMed |
| RAD51 Paralogs and RAD51 Paralog Complexes BCDX2 and CX3 Interact with BRCA2. | bioRxiv | 2024 | 39416194 | PubTator, text mining | PubMed |
| Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers. | Rev Assoc Med Bras (1992) | 2024 | 39356959 | PubTator, text mining | PubMed |
| The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer. | Ann Surg Oncol | 2024 | 39331289 | PubTator, text mining | PubMed |
| What About the Others? Clinical Management of Gynecologic Cancer Risk in Patients With Moderate-Risk Hereditary Cancer Genes ( ATM , BRIP1 , RAD51C , RAD51D , and PALB2 ). | Clin Obstet Gynecol | 2024 | 39324947 | PubTator, text mining | PubMed |
| Validation of the BOADICEA model for epithelial tubo-ovarian cancer risk prediction in UK Biobank. | Br J Cancer | 2024 | 39294438 | PubTator, text mining | PubMed |
| Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort. | Cancers (Basel) | 2024 | 39272924 | PubTator, text mining | PubMed |
| Mechanism of BCDX2-mediated RAD51 nucleation on short ssDNA stretches and fork DNA. | Nucleic Acids Res | 2024 | 39268578 | PubTator, text mining | PubMed |
| Economic evaluation of extended panel analysis in cancer patients with historical NHS diagnostic germline genetic testing - A modeling study based on real-world data. | Eur J Med Genet | 2024 | 39260602 | PubTator, text mining | PubMed |
| Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer. | JAMA Netw Open | 2024 | 39226054 | PubTator, text mining | PubMed |
| Screening of gastric cancer diagnostic biomarkers in the homologous recombination signaling pathway and assessment of their clinical and radiomic correlations. | Cancer Med | 2024 | 39206620 | PubTator, text mining | PubMed |
| Germline RAD51C and RAD51D Mutations in High-Risk Chinese Breast and/or Ovarian Cancer Patients and Families. | J Pers Med | 2024 | 39202057 | PubTator, text mining | PubMed |
| The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. | Cancer Genomics Proteomics | 2024 | 39191493 | PubTator, text mining | PubMed |
| Marginal Contribution of Pathogenic RAD51D Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients. | J Cancer Allied Spec | 2024 | 39156943 | PubTator, text mining | PubMed |
| The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations. | Clin Cancer Res | 2024 | 39150540 | PubTator, text mining | PubMed |
| A Novel JAK2 Fusion in T-Cell Prolymphocytic Leukemia. | Genes Chromosomes Cancer | 2024 | 39133763 | PubTator, text mining | PubMed |
| Four cancer cases with pathological germline variant RAD51D c.270_271dup. | J Obstet Gynaecol Res | 2024 | 39117461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5892/papers?page=8